Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring

Clinical trial NCT00642642 · COMPLETED

Trial details

NCT number: NCT00642642
Sponsor: Castle Creek Biosciences, LLC.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acne Scarring of the Face

Start date: 2007-11-01
Primary completion: 2009-03-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.